JP2013151554A - Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips - Google Patents

Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips Download PDF

Info

Publication number
JP2013151554A
JP2013151554A JP2013086924A JP2013086924A JP2013151554A JP 2013151554 A JP2013151554 A JP 2013151554A JP 2013086924 A JP2013086924 A JP 2013086924A JP 2013086924 A JP2013086924 A JP 2013086924A JP 2013151554 A JP2013151554 A JP 2013151554A
Authority
JP
Japan
Prior art keywords
cells
redifferentiated
immortality
cell
telomere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013086924A
Other languages
Japanese (ja)
Inventor
Isao Kajisa
功 加治佐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2013086924A priority Critical patent/JP2013151554A/en
Publication of JP2013151554A publication Critical patent/JP2013151554A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To perfect eternal youth and immortality by making an improved version 4 of a drug for eternal youth and immortality, and applying latest science.SOLUTION: Eternal youth and immortality is achieved by extending a telomere by the action of T cell redifferentiation of human iPS, eliminating aging inflammation due to somatic cell waste, producing an oral drug of T cells of the iPS by coating them or putting them in a protein "cage", and making a version 4 of an oral drug for eternal youth and immortality.

Description

本発明は、ヒトｉＰＳのＴ細胞再分化テロメア若返り老化炎症止め経口不老不死薬４に関する。The present invention relates to a human iPS T cell redifferentiation telomere rejuvenation aging anti-inflammatory oral immortal medicine 4.

従来、ヒトｉＰＳ細胞初期化利用経口不老不死薬に関する技術はすくなかった。Conventionally, there has been little technology related to oral immortal drugs using human iPS cell reprogramming.

「毎日新聞」２０１３年１月４日、３頁。"Mainichi Newspaper" January 4, 2013, page 3. 「寿命１０００年」２０１２年７月２５日、早川書房ジョナサン・ワイナー。"Life 1000 years" July 25, 2012, Hayakawa Shobo Jonathan Weiner. 「老化は治せる」２０１３年３月２０日、集英社新書、後藤 眞。“Aging can be cured,” March 20, 2013, Shueisha Shinsho, Satoshi Goto.

従来、ヒトｉＰＳ細胞初期化利用経口不老不死薬に関する技術はすくなかったので最新技術よって改良実現させる。  Conventionally, since there are few techniques related to oral immortal drugs using human iPS cell reprogramming, improvement is realized by the latest techniques.

ヒトｉＰＳのＴ細胞初期化後再分化してテロメアを長くし、コーティングかかご入れ経口とし老化炎症止めと細胞のゴミをなくす。  Redifferentiate human iPS after T cell reprogramming to lengthen telomeres and place them in a coated basket orally to eliminate anti-aging inflammation and cell debris.

不老不死の肉体を保てる。  You can keep an immortal body.

以下、本発明の実施例について時系列的に文章で説明する。ヒトｉＰＳのＴ細胞を再分化しテロメアを長く伸ばし若返りの兆候を示す。老化は体細胞の古くなったゴミでの炎症なので再分化Ｔ細胞で老化という炎症止め治し老化の７つの原因の細胞のゴミをこの再分化Ｔ細胞でなくす。またｉＰＳ細胞は増殖するので若返り再分化Ｔ細胞を胃酸や熱で壊れないようにコーティングするか、たんぱく質の「かご」に入れる。従来、再分化Ｔ細胞を細胞中に入れていたが、これを経口式にすることで口から飲むという単純化とした。このようにして全細胞が初期化し細胞のゴミをなくし、血液中のほとんどがＴ細胞であり再分化Ｔ細胞を血液中から体細胞の中へ送り込むことで不老不死を実現する。以上ような特徴を持つヒトｉＰＳのＴ細胞再分化テロメア若返り老化炎症止め経口不老不死薬４。    Hereinafter, embodiments of the present invention will be described in a chronological order in text. Redifferentiates human iPS T cells, lengthens telomeres and shows signs of rejuvenation. Since aging is inflammation caused by old garbage of somatic cells, redifferentiated T cells suppress the inflammation called aging, and the garbage of cells that cause aging is eliminated by these redifferentiated T cells. Since iPS cells proliferate, rejuvenated re-differentiated T cells are coated so as not to be broken by gastric acid or heat, or placed in a protein “cage”. Conventionally, redifferentiated T cells have been placed in the cells, but this is simplified by taking them by mouth by making them oral. In this way, all cells are initialized to eliminate cell dust, most of the blood is T cells, and redifferentiated T cells are sent from blood into somatic cells to achieve immortality. A human iPS T cell redifferentiation telomere rejuvenation aging inflammation-preventing oral immortal medicine 4 having the above characteristics.

上記の非特許文献の如く実施される。Implemented as in the above non-patent literature.

ヒトｉＰＳのＴ細胞再分化テロメア若返り老化炎症止め経口不老不死薬４はヒトｉＰＳ細胞初期化３遺伝子利用経口不老不死薬の改良技術で大きく進歩を遂げ高齢化が進む中この薬の需要の産業上の利用可能性は高いと解される。    Human iPS T cell redifferentiation telomere rejuvenation aging inflammation-preventing oral immortal medicine 4 is an advanced technology for improving human iPS cell reprogramming 3 gene-based oral immortal medicine. It is understood that the availability of is high.

Claims (1)

（イ）Ｔ細胞の老化して弱ったものをｉＰＳ技術でいったん初期化後ｉＰＳ細胞としてＴ細胞に再分化するとテロメアが３０％から５０％長くなり若返りの兆候を示す。
（ロ）老化は体細胞の古くなったゴミでの炎症なので再分化したＴ細胞で老化という炎症を治し、老化の７つの原因の細胞のゴミをこの再分化Ｔ細胞でなくす。
（ハ）またｉＰＳ細胞は増殖するのでその若くなった再分化Ｔ細胞を胃酸や熱で壊れないようにコーティングするか、たんぱく質の「かご」に入れる。従来、再分化Ｔ細胞を細胞中に入れていたが、これを経口式にすることで口から飲むという単純化とした。
（ニ）このようにして全細胞が初期化し細胞のゴミをなくし、血液中のほとんどがＴ細胞であり再分化Ｔ細胞を血液中から体細胞の中へ送り込むことで不老不死を実現する。
以上のような特徴を持つヒトｉＰＳのＴ細胞再分化テロメア若返り老化炎症止め経口不老不死薬４。(A) When T cells are aged and weakened by iPS technology and then re-differentiated into T cells as iPS cells, telomeres become 30% to 50% longer and show signs of rejuvenation.
(B) Since aging is an inflammation of old garbage of somatic cells, the redifferentiated T cells cure the inflammation called aging, and the garbage of the seven causes of aging is eliminated by these redifferentiated T cells.
(C) Since iPS cells proliferate, the young redifferentiated T cells are coated so as not to be broken by gastric acid or heat, or placed in a protein “cage”. Conventionally, redifferentiated T cells have been placed in the cells, but this is simplified by taking them by mouth by making them oral.
(D) In this way, all cells are initialized, cell dust is eliminated, most of the blood is T cells, and redifferentiated T cells are sent from blood into somatic cells, thereby realizing immortality.
A human iPS T cell redifferentiation telomere rejuvenation aging inflammation-preventing oral immortal medicine 4 having the above characteristics.
JP2013086924A 2013-04-01 2013-04-01 Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips Pending JP2013151554A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013086924A JP2013151554A (en) 2013-04-01 2013-04-01 Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013086924A JP2013151554A (en) 2013-04-01 2013-04-01 Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips

Publications (1)

Publication Number Publication Date
JP2013151554A true JP2013151554A (en) 2013-08-08

Family

ID=49048186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013086924A Pending JP2013151554A (en) 2013-04-01 2013-04-01 Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips

Country Status (1)

Country Link
JP (1) JP2013151554A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013231088A (en) * 2013-08-17 2013-11-14 Isao Kajisa AGED ELDERLY PERSON HUMAN iPS 6 FACTOR COATING INITIALIZATION TELOMERE REJUVENATION UTILIZING ELDERLY PERSON'S BRAIN PHOTOELECTRODE STIMULATION WHOLE MEMORY RECALL ORAL IMMORTALITY DRUG
JP2022001603A (en) * 2021-10-14 2022-01-06 功 加治佐 Self-derived iPS Young Blood Application GDF11 Molecular Coating Rejuvenation Oral Immortality 9

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008163042A (en) * 2008-02-08 2008-07-17 Isao Kajisa Oral elixir of life using human ips cell initializing 3 genes
JP2008178692A (en) * 2008-01-15 2008-08-07 Isao Kajisa Immortality device 3, adopting rejuvenation method with application of-out-of-body experience including cyborg made of protein using pluripotent stem cells from adult human fibroblasts
JP2011121988A (en) * 2011-02-09 2011-06-23 Isao Kajisa Protein beverage oral drug 2 for immortality of life using human ips cell initialization 4 gene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008178692A (en) * 2008-01-15 2008-08-07 Isao Kajisa Immortality device 3, adopting rejuvenation method with application of-out-of-body experience including cyborg made of protein using pluripotent stem cells from adult human fibroblasts
JP2008163042A (en) * 2008-02-08 2008-07-17 Isao Kajisa Oral elixir of life using human ips cell initializing 3 genes
JP2011121988A (en) * 2011-02-09 2011-06-23 Isao Kajisa Protein beverage oral drug 2 for immortality of life using human ips cell initialization 4 gene

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6014019100; Ｃｅｌｌ　Ｓｔｅｍ　Ｃｅｌｌ Ｖｏｌ．１２, 201301, ｐ．１１４-１２６ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013231088A (en) * 2013-08-17 2013-11-14 Isao Kajisa AGED ELDERLY PERSON HUMAN iPS 6 FACTOR COATING INITIALIZATION TELOMERE REJUVENATION UTILIZING ELDERLY PERSON'S BRAIN PHOTOELECTRODE STIMULATION WHOLE MEMORY RECALL ORAL IMMORTALITY DRUG
JP2022001603A (en) * 2021-10-14 2022-01-06 功 加治佐 Self-derived iPS Young Blood Application GDF11 Molecular Coating Rejuvenation Oral Immortality 9

Similar Documents

Publication Publication Date Title
JP2015507921A5 (en)
Abu Kasim et al. Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources
EA201291034A1 (en) APTAMERS TO β-NGF AND THEIR APPLICATION IN THE TREATMENT OF B-NGF-MEDIATED DISEASES AND DISORDERS
PH12014501175A1 (en) Medium composition for rejuvenating stem cells
MX2020011415A (en) Methods of using zscan4 for rejuvenating human cells.
ES2685319T3 (en) Generation of pacemaker cells based on transcription factor and methods of use thereof
JP2015159895A5 (en)
WO2014210037A3 (en) A composition of mesenchymal stem cells
AR091539A1 (en) MICRO-ARN miR-15 FAMILY INHIBITORS
JP2016510594A5 (en)
MX2017005425A (en) Methods and compositions particularly for treatment of attention deficit disorder.
JP2013151554A (en) Oral drug for eternal youth and immortality preventing aging inflammation based on telomere rejuvenation caused by redifferentiated t cell of human ips
JP2013177444A (en) ORAL IMMORTALIZATION DRUG 5 FOR HUMAN iPS T CELL REDIFFERENTIATION AND REJUVENATION OF TELOMERE FOR ELIMINATION OF INFLAMMATORY AGING AND DECOMPOSITION OF P53 AND RB
MX2020006944A (en) Ipsc-based vaccine as a prophylactic and therapeutic treatment for cancer.
Jiang et al. Mesenchymal stem cell senescence during aging: from mechanisms to rejuvenation strategies
JP2008163042A (en) Oral elixir of life using human ips cell initializing 3 genes
JP2016510766A5 (en)
ZA202002103B (en) Compounds as mpges-1 inhibitors
BR112015022565A2 (en) compositions and methods for enhancing the therapeutic potential of stem cells
AR120475A1 (en) PRODUCTION OF HEMATOPOIETIC PRECURSOR CELLS
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
ES2514140A1 (en) Use of the inhibitor of steroid sulfatases stx64 for treating aging
JP2013091657A (en) Ips 6 factor coated, caged, initiation-using, elderly person brain photoelectrode-stimulating, whole memory-recovering oral amrita 3
JP2011121988A (en) Protein beverage oral drug 2 for immortality of life using human ips cell initialization 4 gene
Tapia et al. Restoring stem cell function in aged tissues by direct reprogramming?

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140520

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150120